INVASIVE
(Endometrial Biopsy)
ENDORECEPT is an innovative genetic test that assesses endometrial receptivity based on advanced transcriptomic molecular techniques. Through the analysis of the endometrial tissue, the test evaluates the gene expression profile of more than 400 genes specifically involved in endometrial receptivity, identifying a personalized implantation window for each patient.
Learn more
NON-INVASIVE
(Peripheral Blood)
ENDORECEPT Blood is a non-invasive test for the assessment of endometrial receptivity. Using a simple blood sample, it analyzes approximately 300 specific biomarkers composed of microRNAs (miRNAs), which are capable of regulating more than 1,000 genes related to endometrial receptivity, in order to define a personalized implantation window for each patient.
Learn more
Indication for testing
Patients with a clinical hystory of Repeated Implantation Failure 1
Patients
with BMI >30 2,3
Patients with endometrial atrophy (endometrial thickness < 6mm) 4
Patients
with adenomyosis 5
Patients with recurrent biochemical pregnancies 6
Limited number of high-quality embryos
Age ≥ 35 years
1 Simón C, et al. Reproductive BioMedicine Online 2020
2 Comstock IA, al. Fertil Steril. 2017
3 Bellver, et al. Reprod. Sci. 2021
4. Valbuena D, et al. In HUMAN REPRODUCTION 2016 (ESHRE)
5. Mahajan N, et al. Journal of human reproductive sciences. 2018
6. Díaz-Gimeno P, et al. Fertil Steril. 2017